We know that advancing patient outcomes relies on more than clinical data alone. Our Global Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) Team focuses on collecting real-world insights, which includes our development of novel patient-reported outcomes (PRO) tools to assess treatment benefit and burden of disease.
With achieving approvals for two medicines and advancing a broad pipeline of investigational therapies, we have a proven track record of discovering, developing and commercializing innovative medicines that target root causes of disease.
View our pipeline ______________ View our approved medicines ___________ Read about our core programs
Our world-leading expertise in mast cell and cancer biology powers the relentless development of transformational medicines. We believe our progress in the clinic reflects the power of our platform to rapidly and reproducibly pursue highly selective medicines against diverse, difficult-to-drug targets.
Read more about our scientific platform
Patients are at the center of Blueprint Medicines’ mission to discover, develop and deliver innovative medicines that address significant medical needs. From conducting rigorous clinical trials and supporting medical research, to successfully registering our medicines with global health authorities and providing a robust U.S. patient support program for our approved medicines through YourBlueprint®, we aim to bring innovative treatments to the greatest number of patients who may benefit, as quickly and responsibly as possible.
Learn about our ongoing clinical trials Read our policy on early access Find out about our U.S. patient support program, YourBlueprint® Learn how we support investigator sponsored trials1-888-BLU-PRNT (1-888-258-7768)
+31 85 064 4001
YourBlueprint® patient support program
1-888-BLUPRNT (1-888-258-7768)
Monday-Friday, 8 a.m. to 8 p.m. ET
YourBlueprint.com or YourBlueprint.com/HCP
